Article Details

Palisade Bio (NASDAQ:PALI) Upgraded to “Hold” at Zacks Investment Research - KOP Source

Retrieved on: 2022-05-01 12:09:00

Tags for this article:

Click the tags to see associated articles and topics

Palisade Bio (NASDAQ:PALI) Upgraded to “Hold” at Zacks Investment Research - KOP Source. View article details on hiswai:

Excerpt

According to Zacks, “Palisade Bio Inc. is a late-stage biopharma company advancing therapies which help patients with acute and chronic ...

Article found on: www.kopsource.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up